# Unspecified GI

## Length of Authorizations

365 Days except 3 days for Aemcolo

## All Authorizations:

Must be prescribed in accordance with FDA approved labeling

## Step Therapy Criteria

-   Must have had an inadequate clinical response to at least **14 days** with at least **two preferred** drugs

## Non-Preferred Criteria

-   Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    -   For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
-   Must have had an inadequate clinical response of at least **14 days** with at least **three preferred** drugs, if indicated for diagnosis
    -   For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    -   For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)

## Formulary

Gastrointestinal Agents: Unspecified GI

| PREFERRED                    | NON-PREFERRED |
|------------------------------|---------------|
| Amitiza BvG ST               | Aemcolo       |
| Bisacodyl                    | Gattex        |
| Casanthranol/Docusate Sodium | Ibsrela       |
| Dicyclomine                  | Linzess 72mcg |
| Diphenoxylate/Atropine       | Lubiprostone  |
| Lactulose                    | Motegrity     |
| Linzess ST 145, 290mcg       | Mytesi        |
| Loperamide                   | Relistor      |
| Movantik ST                  | Symproic      |
| Polyethylene Glycol          | Trulance      |
| Psyllium Fiber               | Zorbitive     |
| Senna                        |               |
| Xifaxan ST                   |               |

### Link to Criteria

[Gastrointestinal Agents: Unspecified GI](https://pharmacy.medicaid.ohio.gov/sites/default/files/20220415_UPDL_Criteria_FINAL_.pdf#page=65)
